Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 9/20 | 0.42 |
| ▸ | DRD2 | P14416 | 2/20 | 0.38 |
| ▸ | DRD1 | P21728 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 2/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8790729 | 0.85 | MGLL (0.40) | TAAR1DRD2SLC6A3MAOASLC6A4 | |
| SCHEMBL28735744 | 0.83 | TAAR1 (0.50) | TAAR1DRD2DRD1MEN1KMT2A | |
| SCHEMBL2642831 | 0.82 | TAAR1 (0.57) | TAAR1DRD2DRD1HTR6SLC6A3 | |
| SCHEMBL3278988 | 0.81 | — | — | |
| SCHEMBL5539551 | 0.79 | MAOA (0.56) | TAAR1MAOAMAOBKCNH2LOXL2 | |
| SCHEMBL2642541 | 0.77 | TDP1 (0.52) | TAAR1DRD2DRD1 | |
| SCHEMBL3031250 | 0.77 | TAAR1 (0.38) | TAAR1DRD2DRD1MEN1KMT2A | |
| SCHEMBL1805140 | 0.77 | CNR1 (0.42) | TAAR1DRD2DRD1 | |
| SCHEMBL2642924 | 0.76 | — | — | |
| SCHEMBL5542870 | 0.76 | HTR2A (0.48) | SLC6A3MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11581567-B2 | Lithium ion battery and electrolyte thereof | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2023-02-14 | — | — | US | disclosed |
| US-10971757-B2 | Lithium-ion battery and its electrolyte | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2021-04-06 | — | — | US | disclosed |
| US-10826120-B2 | Lithium-ion battery and its electrolyte | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2020-11-03 | — | — | US | disclosed |
| US-20200020981-A1 | LITHIUM-ION BATTERY AND ITS ELECTROLYTE | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2020-01-16 | — | — | US | disclosed |
| EP-3442072-B1 | LITHIUM-ION BATTERY AND ELECTROLYTE THEREFOR | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2019-10-02 | — | — | EP | disclosed |
| EP-3367491-B1 | LITHIUM ION BATTERY AND ELECTROLYTE THEREOF | CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) | 2019-08-21 | — | — | EP | disclosed |
| US-10381681-B2 | Electrolyte and lithium-ion battery containing the same | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2019-08-13 | — | — | US | disclosed |
| EP-3444886-A1 | LITHIUM ION BATTERY AND ELECTROLYTE THEREOF | Contemporary Amperex Technology Co., Limited (CN) | 2019-02-20 | — | — | EP | disclosed |
| EP-3442072-A1 | LITHIUM ION BATTERY AND ELECTROLYTE THEREOF | Contemporary Amperex Technology Co., Limited (CN) | 2019-02-13 | — | — | EP | disclosed |
| EP-3367491-A1 | LITHIUM ION BATTERY AND ELECTROLYTE THEREOF | Contemporary Amperex Technology Co., Limited (CN) | 2018-08-29 | — | — | EP | disclosed |
| US-20180241078-A1 | LITHIUM ION BATTERY AND ELECTROLYTE THEREOF | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2018-08-23 | — | — | US | disclosed |
| US-20170346132-A1 | ELECTROLYTE AND LITHIUM-ION BATTERY CONTAINING THE SAME | CONTEMPORARY AMPEREX TECHNOLOGY (HONG KONG) LIMITED (CN) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11581567-B2 | Lithium ion battery and electrolyte thereof | PLCB1, PLCB3, LAGE3 | TAAR1 3782/4885DRD2 4240/4885DRD1 4464/4885 |
| US-20180241078-A1 | LITHIUM ION BATTERY AND ELECTROLYTE THEREOF | PLCB1, PLCB3, LAGE3 | TAAR1 3782/4885DRD2 4240/4885DRD1 4464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.